Qian Xue Selected Research

Qian Xue Research Topics

Disease

10	Neoplasms (Cancer) 08/2022 - 10/2008
3	Ischemic Stroke 06/2022 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 08/2008
3	Infections 04/2021 - 01/2020
2	Inflammation (Inflammations) 06/2022 - 08/2021
2	Hypertension (High Blood Pressure) 05/2022 - 01/2021
2	Stroke (Strokes) 02/2022 - 01/2022
2	Fibrosis (Cirrhosis) 08/2021 - 12/2015
2	Neoplasm Metastasis (Metastasis) 02/2017 - 05/2016
2	Body Weight (Weight, Body) 01/2015 - 10/2008
1	Hemorrhage 07/2022
1	Type 2 Diabetes Mellitus (MODY) 04/2022
1	Autistic Disorder (Autism) 01/2022
1	Cerebral Infarction 10/2021
1	Triple Negative Breast Neoplasms 10/2021
1	Margins of Excision 09/2021
1	Erythema 04/2021
1	Hyperemia 04/2021
1	Neuroinflammatory Diseases 01/2021
1	Fatty Liver 01/2021
1	Nasopharyngeal Carcinoma 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 02/2020
1	Gout 01/2020
1	Pain (Aches) 01/2020
1	Influenza in Birds (Avian Flu) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Colitis 10/2019
1	Atherosclerosis 02/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Blindness (Hysterical Blindness) 01/2019
1	Myxoma (Myxomas) 03/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Abdominal Pain (Pain, Abdominal) 12/2017
1	Liver Abscess 12/2017
1	Rhabdomyolysis 12/2017
1	Fever (Fevers) 12/2017
1	Pyogenic Liver Abscess 12/2017
1	Atrial Fibrillation 12/2016
1	Lung Neoplasms (Lung Cancer) 05/2016

Drug/Important Bio-Agent (IBA)

5	Long Noncoding RNAIBA 06/2022 - 05/2020
4	Pharmaceutical PreparationsIBA 05/2022 - 08/2008
4	Messenger RNA (mRNA)IBA 10/2021 - 10/2019
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2020
3	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2014
2	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 02/2017
2	AntioxidantsIBA 05/2022 - 01/2021
2	CytokinesIBA 04/2022 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 02/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 10/2021 - 02/2017
2	Immunoglobulin E (IgE)IBA 04/2021 - 02/2011
2	LipidsIBA 01/2021 - 01/2019
2	Pattern Recognition ReceptorsIBA 02/2020 - 02/2011
2	Scutellaria barbata extractIBA 10/2008 - 08/2008
1	MetalsIBA 08/2022
1	Proteasome InhibitorsIBA 08/2022
1	Ubiquitinated ProteinsIBA 08/2022
1	Bortezomib (Velcade)FDA Link 08/2022
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 08/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2022
1	Caspase 3 (Caspase-3)IBA 08/2022
1	UbiquitinIBA 08/2022
1	intersectin 1IBA 06/2022
1	BilirubinIBA 05/2022
1	ThioredoxinsIBA 05/2022
1	Antihypertensive Agents (Antihypertensives)IBA 05/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022
1	C-Reactive ProteinIBA 02/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2021
1	AlbuminsIBA 10/2021
1	GlobulinsIBA 10/2021
1	CalciumIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 08/2021
1	calcipotriene (calcipotriol)FDA LinkGeneric 04/2021
1	Purinergic P2X3 ReceptorsIBA 01/2021
1	NucleotidesIBA 05/2020
1	Nucleic AcidsIBA 05/2020
1	InterferonsIBA 02/2020
1	methylcyanocarbamate dimerIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	SodiumIBA 10/2019
1	B7-H1 AntigenIBA 10/2019
1	Dextrans (Dextran)FDA Link 10/2019
1	Transcription Factors (Transcription Factor)IBA 02/2019
1	AfatinibIBA 01/2018
1	TeaIBA 12/2017
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2016

Therapy/Procedure

5	Therapeutics 08/2022 - 02/2017
3	Length of Stay 07/2022 - 05/2016
3	Blood Transfusion (Blood Transfusions) 07/2022 - 12/2016
2	Artificial Respiration (Mechanical Ventilation) 12/2016 - 05/2016
1	Surgical Instruments (Clip) 05/2022
1	First Aid (Aids, First) 01/2022
1	Chemoradiotherapy 01/2021
1	Corneal Transplantation (Keratoplasty) 01/2019
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2018